Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AllMed International is a pharmaceutical distribution and marketing company that specializes in providing generic medicines to international markets, with a strong historical presence in Eastern Europe, particularly Ukraine. The company focuses on distributing generic oncology therapeutics, such as erlotinib and zoledronic acid, as well as essential anti-tuberculosis medications like ethambutol, isoniazid, rifampicin, and protionamide. AllMed International collaborates closely with major Indian pharmaceutical manufacturers, including Svizera Labs and Natco Pharma, to source and supply high-quality, cost-effective generic formulations. Through these partnerships, the company plays a key role in expanding access to critical treatments for infectious diseases and cancer in developing healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AllMed International.